Semaglutide Reduces Rates of Cardiovascular, COVID-19-Related Deaths - HCPLive

Retrieved on: 2024-09-07 21:02:12

Tags for this article:

PEPTIDE THERAPEUTICS

Peptide hormones

In Denmark

In science

Semaglutide

Anti-obesity medication

Diabetes

Cardiovascular disease

Weight loss

Obesity

Benjamin M. Scirica

Click the tags to see associated articles and topics

Semaglutide Reduces Rates of Cardiovascular, COVID-19-Related Deaths - HCPLive. View article details on hiswai:

Summary

The article discusses a study by Benjamin M. Scirica indicating that semaglutide, a peptide therapeutic, reduced COVID-19-related and cardiovascular deaths among overweight patients in Denmark. This ties the key concept 'Covid 19' to relevant tags like 'Peptide therapeutics', 'Cardiovascular disease', and 'Benjamin M. Scirica'.

Article found on: www.hcplive.com

View Original Article